Speakers: Hisatake Matsumoto, Ph.D. (Assistant Professor at Osaka University)
Combination of clinically significant proteins in plasma defines phenotype and combined biomarker associated with prognosis in critical COVID19 patients: Analysis using Olink PEA technology
Jan 27, 2022 3:06:24 PM / by Olink posted in Infectious diseases, Clinical research, Covid19, User group meetings
Targeted discovery proteomics in cardiovascular clinical trials
Jan 27, 2022 2:00:37 PM / by Olink posted in Cardiovascular diseases, Clinical research, User group meetings
Speakers: Christopher R. deFilippi, M.D. (Vice-Chairman of Academic Affairs at Inova Heart and Vascular Institute)
Exploring molecular phenotypes of incident breast cancer through population-based proteogenomics
Dec 3, 2021 10:04:35 AM / by Olink posted in Oncology, Multiomics, Clinical research, Population based studies
Speakers: Dr. Anders Mälarstig Director of Target Sciences Pfizer Worldwide Research and Development
Maximizing the power of proteomic clinical trial profiling for better actionable insights - a new collaborative initiative from the SCALLOP consortium
Aug 12, 2021 10:31:53 AM / by Olink posted in Multiomics, Clinical research, Drug discovery & development, Proteogenomics
Speakers: Anders Mälarstig, Direct of Target science at Pfizer
High-throughput proteomics as a keystone in multiomic approaches to COVID-19 research
Aug 12, 2021 10:31:18 AM / by Olink posted in Infectious diseases, Clinical research, Covid19
Speakers: Niklas Björkström, Associate Professor at Karolinska University Hospital & Fridtjof Lund-Johansen, MD at Oslo University Hospital
Protein biomarkers in plasma: revealing biological insights into tumor microenvironment
Aug 12, 2021 10:30:47 AM / by Olink posted in Immunotherapy, Oncology, Multiomics, Clinical research
Speakers: Genevieve Boland, Associate Professor of Surgery at Harvard Medical School & Arnav Mehta, Postdoctoral researcher in Immunology at the Broad Institute of MIT and Harvard
Analysis of a Wellness Cohort Identifies Markers of Metastatic Cancer Years Prior to Diagnosis
Aug 12, 2021 10:30:09 AM / by Olink posted in Oncology, Wellness, Clinical research
Speakers: Andrew Magis, Director of Data Science at the Institute for Systems Biology
Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis
Aug 12, 2021 10:28:54 AM / by Olink posted in Cardiovascular/metabolic diseases, Clinical research
Speakers: Guillaume Pare, Professor at McMaster University and Senior scientist at Population Health Research Institute, Canada
Investigating cellular pathways driving severe COVID-19: Fresh insights from longitudinal plasma proteomics
Aug 12, 2021 10:25:34 AM / by Olink posted in Infectious diseases, Clinical research, Covid19
Speakers: Michael Filbin, Emergency Physician and Director of clinical research in the Department of Emergency Medicine at Massachusetts General Hospital (MGH) & Arnav Mehta, Postdoctoral Researcher in Nir Hacohen and Eric Lander’s labs at the Broad Institute of MIT and Harvard
Human immunity to SARS-CoV-2
Aug 12, 2021 10:25:04 AM / by Olink posted in Infectious diseases, Clinical research, Covid19
Speakers: Prabhu Arunachalam from Dr. Bali Pulendran’s lab at Stanford University